Brett Sandercock - Sep 10, 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Financial Officer
Signature
Brett Sandercock, Chief Financial Officer
Stock symbol
RMD
Transactions as of
Sep 10, 2021
Transactions value $
-$1,342,250
Form type
4
Date filed
9/13/2021, 04:17 PM
Previous filing
Aug 23, 2021
Next filing
Oct 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Options Exercise $144K +2.5K +2.78% $57.76 92.3K Sep 10, 2021 Direct F1
transaction RMD ResMed Common Stock Sale -$1.49M -5K -5.42% $297.33 87.3K Sep 10, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -2.5K -8.33% $0.00 27.5K Sep 10, 2021 ResMed Common Stock 2.5K $57.76 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 Represents date options first became exercisable. Options vest 1/3 per year.